Kathryn Ellis
Kathryn Ellis
Verified email at unimelb.edu.au
Title
Cited by
Cited by
Year
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
14362013
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ...
Alzheimer's & dementia 10 (6), 844-852, 2014
12582014
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
9322010
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
7782011
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of …
K Ellis, A Bush, D Darby, D De Fazio, J Foster, P Hudson, ...
Cambridge University Press, 2009
5632009
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
3702010
Blood-based protein biomarkers for diagnosis of Alzheimer disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of neurology 69 (10), 1318-1325, 2012
3522012
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
EM Moore, AG Mander, D Ames, MA Kotowicz, RP Carne, H Brodaty, ...
Diabetes care 36 (10), 2981-2987, 2013
3112013
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies
LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ...
Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015
2632015
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ...
Neurology 74 (2), 121-127, 2010
2332010
Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective …
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
Lancet Neurol 12 (4), 357-367, 2013
2282013
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations
PA Yates, VL Villemagne, KA Ellis, PM Desmond, CL Masters, CC Rowe
Frontiers in neurology 4, 205, 2014
2202014
Implementation of subjective cognitive decline criteria in research studies
JL Molinuevo, LA Rabin, R Amariglio, R Buckley, B Dubois, KA Ellis, ...
Alzheimer's & Dementia 13 (3), 296-311, 2017
2162017
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ...
Brain 135 (7), 2126-2139, 2012
2152012
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
S Frost, Y Kanagasingam, H Sohrabi, J Vignarajan, P Bourgeat, ...
Translational psychiatry 3 (2), e233-e233, 2013
1962013
Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ...
Annals of neurology 74 (6), 905-913, 2013
1832013
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ...
Molecular psychiatry 18 (8), 875-881, 2013
1802013
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
G Chetelat, VL Villemagne, N Villain, G Jones, KA Ellis, D Ames, ...
Neurology 78 (7), 477-484, 2012
1682012
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease
YY Lim, P Maruff, RH Pietrzak, D Ames, KA Ellis, K Harrington, ...
Brain 137 (1), 221-231, 2014
1672014
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ...
JAMA neurology 70 (7), 903-911, 2013
1632013
The system can't perform the operation now. Try again later.
Articles 1–20